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Marco G. Casarotto, and Angela F. Dulhunty*
John Curtin School of Medical Research, Australian National University, Canberra, AustraliaABSTRACT Although it has been suggested that the C-terminal tail of the b1a subunit of the skeletal dihyropyridine receptor
(DHPR) may contribute to voltage-activated Ca2þ release in skeletal muscle by interacting with the skeletal ryanodine receptor
(RyR1), a direct functional interaction between the two proteins has not been demonstrated previously. Such an interaction is
reported here. A peptide with the sequence of the C-terminal 35 residues of b1a bound to RyR1 in affinity chromatography. The
full-length b1a subunit and the C-terminal peptide increased [
3H]ryanodine binding and RyR1 channel activity with an AC50 of
450–600 pM under optimal conditions. The effect of the peptide was dependent on cytoplasmic Ca2þ, ATP, and Mg2þ concen-
trations. There was no effect of the peptide when channel activity was very low as a result of Mg2þ inhibition or addition of 100 nM
Ca2þ (without ATP). Maximum increases were seen with 1–10 mMCa2þ, in the absence of Mg2þ inhibition. A control peptide with
the C-terminal 35 residues in a scrambled sequence did not bind to RyR1 or alter [3H]ryanodine binding or channel activity. This
high-affinity in vitro functional interaction between the C-terminal 35 residues of the DHPR b1a subunit and RyR1may support an
in vivo function of b1a during voltage-activated Ca
2þ release.INTRODUCTIONContraction in skeletal muscle fibers depends on the rapid
release of Ca2þ ions from the internal sarcoplasmic retic-
ulum (SR) Ca2þ store following a surface membrane action
potential. This excitation-contraction (EC) coupling process
is likely to depend on a physical interaction between the
dihydropyridine receptor (DHPR) voltage sensor in the
transverse (t)-tubule membrane and the ryanodine receptor
(RyR1) Ca2þ release channel in the closely opposed SR
membrane (1,2). Of the five subunits of the DHPR, the
skeletal isoforms of the membrane-spanning a1S subunit
and the cytoplasmic b1a subunit are essential for the skeletal
muscle EC coupling mechanism (2–5), which is defined as
EC coupling that does not depend on external Ca2þ entry.
In the a1S subunit, a central segment of the intracellular
II-III loop (amino acid residues 724–760) between the
second and third transmembrane repeats forms a minimal
essential region for transmitting the EC coupling signal
from the voltage sensor in the a1S subunit to the RyR1
Ca2þ release complex in the SR membrane. Deletion/muta-
tion of this region abolishes skeletal-type EC coupling.
The b1a subunit plays two roles in skeletal EC coupling.
It has an essential role in targeting the DHPR to a precise
position in the t-tubule membrane that will allow it to
interact physically with the RyR (4). This targeting depends
on the well-characterized binding of the guanylate kinase
(GK) domain of b1a to the I-II loop of the a1S subunit. In
addition to this essential role, several findings suggest that
the b1a subunit may play a direct role in the physical EC
coupling process. Beurg et al. (6) reported that deletion ofSubmitted August 2, 2010, and accepted for publication January 10, 2011.
*Correspondence: angela.dulhunty@anu.edu.au
Editor: Michael D. Stern.
 2011 by the Biophysical Society
0006-3495/11/02/0922/9 $2.00the 35-residue C-terminal tail of b1a led to a significant
reduction in depolarization-induced Ca2þ release from the
SR through RyR1 in b1a-null mouse myotubes transfected
with mutant b1a c-DNA. This C-terminal modification did
not appear to affect targeting of the DHPR to RyR1 (6).
Furthermore, Cheng et al. (7) demonstrated a direct interac-
tion between the b1a subunit and RyR1 by affinity chroma-
tography using RyR1 fragments, and by interrupting
b1a binding by deleting or substituting the basic residues
K3494–R3502 in RyR1. Finally, in a study by Schredelseker
et al. (8), expression of the b1a subunit in b1a-null zebrafish
restored targeting of the DHPR to the RyR and skeletal EC
coupling, whereas expression of the cardiac/neuronal b2a or
housefly bM subunits restored targeting of the DHPR to
RyRs but not skeletal EC coupling. This result could be
explained by a direct contribution of b1a to EC coupling.
However, the results could equally well be explained by
an allosteric influence of b1a on the precise geometry of
the DHPR and RyR in the surface/SR junction that reduced
the efficacy of EC coupling (8).
These studies indicate that there may be a direct interac-
tion between b1a and RyR1 in vivo; however, the functional
consequence of the interaction between the b1a subunit and
the RyR1 protein has not previously been reported. In addi-
tion, although the C-terminal tail of b1a has been implicated
in voltage-activated Ca2þ release, binding of the C-terminal
tail to RyR1 has not previously been reported. Therefore, we
examined interactions between the isolated RyR1 channel
and the b1a subunit and its C-terminal tail. We explored
the ability of the 35-residue C-tail of b1a to bind to RyR1
using affinity chromatography, and the ability of the full-
length b1a subunit and its C-terminal tail peptide to interactdoi: 10.1016/j.bpj.2011.01.022
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bilayer and [3H]ryanodine-binding experiments.MATERIALS AND METHODS
Expression and purification of the DHPR b1a
subunit protein
The His-ubiquitin-b1a vector was generated by inserting the b1a cDNA
(GenBank accession No. NM_031173) in-frame downstream of a poly-
histidine-tagged ubiquitin sequence in the plasmid pHUE (9). The construct
was checked by sequencing to exclude amplification error. The plasmid was
transformed into Escherichia coli BL21 and the cells were grown at 37C.
Fusion protein expression was induced by addition of 0.1 mM isopropyl
b-D-thiogalactoside to the culture medium. The cells were spun, resus-
pended in phosphate buffer A (300 mM NaCl, 8 M Urea, 5 mM imidazole,
12 mM BME, 10% glycerol, pH 8), and briefly sonicated. The suspension
was centrifuged at 11,000  g for 30 min. The supernatant was incubated
with Ni-nitrilotriacetic acid agarose (Qiagen, Valencia, CA) for 1 h with
gentle agitation. Ni-nitrilotriacetic acid agarose beads were packed into
a Polyprep column (Bio-Rad), washed with buffer A plus 10 mM imidazole,
and eluted with buffer A plus 250 mM imidazole. Urea was adjusted to
2.6 M by addition of buffer Awithout urea. Ubiquitin was cleaved by diges-
tion with a His-tagged ubiquitin protease (9). Imidazole and ubiquitin
protease were removed by dialysis against buffer A, and ubiquitin was
removed by Ni-agarose chromatography. The b1a protein was purified by
denaturing preparative electrophoresis in a Bio-Rad model 491 prep cell,
and eluted with 25 mM Tris/HCl and 192 mM glycine, pH 8.3. The protein
was precipitated with acetone to remove sodium dodecyl sulfate (SDS),
resuspended in 6 M guanidine hydrochloride, dialyzed against phosphate
buffer (300 mM NaCl, pH 8), and stored at 70C.Peptide synthesis
The following peptides were synthesized by the Biomolecular Resource
Facility of the John Curtin School of Medical Research (Australian
National University, Canberra, Australia) with the use of an Applied
Biosystems 430A peptide synthesizer, with purification to 98–100%, by
high-performance liquid chromatography and mass spectroscopy. Addi-
tional HPLC purification steps were required with the hydrophobic
b1a peptide to obtain the desired purity and prevent peptide aggregation:
b1a peptide:
490VQVLTSLRRNLSFWGGLEASPRGGDAVAQPQ
EHAM524
Biotinylated b1a C-tail peptide: Biotin-SNLQ-VQVLTSLRRNLSFWG
GLEASPRGGDAVAQPQEHAM
bscrambled peptide: GEAVLAPLGFQSHPNGLQARLVWSDGSRQVT
MREA
Biotinylated bscrambled peptide: Biotin-SNLQ-GEAVLAPLGFQSHPNG
LQARLVWSDGSRQVTMREA
An additional four residues were added to the N-terminals of the b1a and
bscrambled peptides as a linker to biotin. Stock peptide (1 mM in H2O) was
frozen in 20 ml aliquots.SR vesicle isolation, [3H]ryanodine binding,
single-channel recording, and analysis
Rabbit skeletal SR vesicles were isolated and [3H]ryanodine binding was
performed as described previously (10), except that for the [3H]ryanodine
binding, the buffer contained 150 mM NaCl, 20 mM MOPS, 1 mM
CaCl2 with BAPTA for the desired [Ca
2þ] (determined with a Ca2þ elec-
trode); the filters were washed four times with 20 mM MOPS and
150 mM NaCl; and the SR vesicles were preincubated with peptides for
30 min on ice. In some cases, a mixture of 5 mg/ml g-globulins and5 mg/ml bovine serum albumin in 200 mM NaCl with 10% (w/v) polyeth-
ylene glycol was added after washing. The use of polyethylene glycol in
early experiments did not alter [3H]ryanodine binding.
For single-channel experiments, SR vesicles were incorporated into lipid
bilayers (11) via a cis (cytoplasmic) solution containing 230 mM
CsCH3O3S, 20 mM CsCl, 1.0 mM CaCl2, 10 mM TES, and 500 mM
mannitol (pH 7.4 with CsOH) and a trans (luminal) solution containing
30 mM CsCH3O3S, 20 mM CsCl, 1.0 mM CaCl2, and 10 mM TES (pH
7.4). After RyR incorporation was achieved, the cis solution was replaced
with a similar solution with BAPTA added in amounts determined using
a Ca2þ electrode, for the desired free [Ca2þ]. After RyR1 was incorporated,
200 mM CsCH3O3S was added to the trans solution to achieve a symmet-
rical 250 mM Csþ. The bilayer potential, Vcis-Vtrans, was switched between
40 mVandþ40 mVevery 30 s. Channel activity under each condition was
analyzed over 90–180 s using the program Channel 2 (developed by P. W.
Gage and M. Smith, John Curtin School of Medical Research). The
threshold levels for channel opening were set to exclude baseline noise at
~20% of the maximum single-channel conductance and open probability
(PO), mean open time (TO), and mean closed time (TC) measured. The
peptide concentration dependence of relative PO (
RPO) was fitted with
a standard Hill equation (12):
RPO ¼ RPOmin þ ðRPOmax  RPOminÞ

1=

1þ ðAC50=½XÞ^Ha

;
where RPOmax and
RPOmin are the relative PO of the minimally and maxi-
mally activated channels, respectively; AC is the b peptide or b50 1a 1a
subunit concentration for half-maximal activation; Ha is the Hill coeffi-
cient; and X is the concentration of b1a peptide or subunit. The least-squares
method was used to fit the equation to the data.RyR1 purification
RyR1 was solubilized and purified as described previously (13). Sucrose
gradient fractions containing purified RyR1 (identified by SDS-PAGE)
were concentrated using a Vivaspin 20 tube (Sartorius Stedim Biotech,
Bohemia, NY), frozen in 15 ml aliquots, and stored at 70C.Steptavidin agarose and affinity chromatography
Streptavidin-agarose was prepared according to the manufacturer’s specifi-
cations (Thermoscientific, Rockford, IL) and diluted to 50% in wash buffer
(150 mMNaCl, 20 mMMOPS, 1 mMBAPTA, and ~1 mMCaCl2, added in
amounts determined by means of a Ca2þ electrode) to obtain 10 mM Ca2þ.
The streptavidin-agarose was preincubated at 4C overnight with SR vesi-
cles or purified RyR1 to saturate nonspecific binding and then incubated/
rotated with biotinylated peptide for 3 h at room temperature. The mixture
was centrifuged (5) to remove unbound peptide. SR vesicles and purified
SR were incubated with streptavadin-agarose-bound biotinylated bscrambled
or b1a peptide or with streptavadin-agarose alone at 4
C for 48–72 h.
Unbound protein was removed by five centrifugations (500  g, 5 min)
at 4C. The washed pellet (streptavadin-agarose complex) was added to
sample buffer (250 mM Tris HCL (pH 6.8), 40% glycerol, 10% SDS,
20% mercaptoethanol, and 0.1% bromophenol blue) and boiled for 5
min. The supernatant was run on SDS-PAGE, transferred, and immunode-
tected (10,11). The membrane was cut in half to allow separate detection of
RyR1 with anti-RyR1 antibody and biotinylated peptide with StrepTactin.Statistics
Average data are given as the mean5 SE. Statistical significance was eval-
uated by means of a paired or unpaired Student’s t-test or analysis of vari-
ance as appropriate. The numbers of observations (N) are given in the figure
legends. Additional high-performance liquid chromatography purification
steps were required with the hydrophobic b1a peptides to obtain the desired
purity and to prevent peptide aggregation. For the data shown in Figs. 2–4,Biophysical Journal 100(4) 922–930
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FIGURE 1 Binding of the 35-residue b1a C-terminal tail peptide to RyR1
and purification of the recombinant b1a subunit. (A) Western blots showing
binding of the native RyR1 in SR vesicles (lane 7) and the purified RyR1
(lane 6) to the biotinylated 35-residue b1a C-terminal tail peptide coupled
to streptavidin-agarose (highlighted). The peptide was detected with Strep-
Tactin, and RyR1 was detected with anti-RyR1 antibody. The bscrambled
peptide did not bind to either native (lane 9) or purified RyR1 (lane 8). Posi-
tive controls: purified RyR1 and SR vesicles containing native RyR1 aloneRESULTS
Binding of the b1a protein and its C-tail to RyR1
The full-length b1a subunit has been shown to bind to a frag-
ment of RyR1 (7). We show here the 35-residue C-tail
peptide binds to the full-length RyR1 (Fig. 1). Fig. 1 A
shows that when the biotinylated b1a peptide was coupled
to streptavidin-agarose, it bound both native RyR1 in SR
vesicles and purified RyR1 (lanes 6 and 7, shaded gray).
Thus, the tiny 35-residue C-tail peptide bound to and precip-
itated full-length RyR1. In control experiments, no RyR
bound to streptavidin-agarose in the absence of biotinylated
b1a peptide (lanes 10 and 11), and streptavidin-agarose
coupled to biotinylated bscrambled peptide did not bind to
RyR1 in SR vesicles or purified RyR1 (lanes 8 and 9). Posi-
tive controls are shown for the two peptides (lanes 2 and 3),
for native RyR1 (lane 3) and purified RyR1 (lane 4). These
results indicate that binding of the peptide to RyR1 is
specific and requires the native C-tail sequence.in lanes 2 and 3, respectively; and biotinylated b1a and bscrambled peptides
alone in lanes 4 and 5, respectively. Lane 1 contained streptavidin-agarose
alone, lane 10 contained streptavidin-agarose incubated with purified
RyR1, and lane 11 contained streptavidin-agarose incubated with SR vesi-
cles. (B) A Coomassie blue-stained 10% SDS-PAGE gel (CG, left) and
Western blot (WB, right) probed with anti-b1a antibody. The first lane
shows purified b1a subunit and the second lane shows molecular mass
markers; 5 mg and 2.5 mg of b1a subunit were loaded for the Coomassie
gel and Western blot, respectively.The b1a subunit increases RyR1 channel activity
with 10 mM cis [Ca2D]
The b1a subunit (Fig. 1 B) increased the activity of native
RyR1 channels in lipid bilayers when added to the cyto-
plasmic (cis) solution. Each channel was exposed to one
concentration of b1a subunit for 15–20 min and then the
b1a subunit was removed by perfusion. An increase in
activity was apparent within 1 min of addition of only 10
nM of the protein, and this was maintained until the b1a
was removed by perfusion, when activity fell toward control
levels (Fig. 2 A). However, the effect of b1a was not always
reversible within the lifetime of the bilayer (10–20 min after
perfusion), with only 15 of 27 channels showing a decrease
in activity after washout of R10 nM of b1a protein. This
poor reversibility likely reflects the high-affinity binding
of the b1a subunit to the RyR1 channel.
The effects of the b1a subunit on channel activity were
similar at þ40 and 40 mV. For example, there was an
average 2.3 5 0.4-fold increase in PO at þ40 mV and
3.85 1.0-fold at40 mVwith 100 nM b1a subunit (average
POB/POC for individual experiments). Therefore, measure-
ments at þ40 and 40 mV were included in the average
data. There was a significant increase in average relative
open probability (PO for each channel with the subunitBiophysical Journal 100(4) 922–930compared with its internal control before exposure to
protein, i.e., logPOB-logPOC) with [subunit] R10 nM
(Fig. 2 B). The increase in PO was due to significantly longer
open times (Fig. 2 C) and shorter closed times (Fig. 2 D).
The ~5-fold reduction in closed times (Fig. 2 D) was greater
than expected from the ~3-fold increase in open times, indi-
cating that the b1a subunit destabilized the closed state of the
channel in addition to stabilizing the open state (see below).
Buffer alone, added at the same volume as with 1 mM
protein, did not alter channel activity (Fig. 2, B–D, first bar).The b1a C-tail peptide increases RyR1 channel
activity with 10 mM cis [Ca2D]
The 35-residue b1a peptide was as effective as the full-length
protein at increasing RyR1 channel activity (Fig. 3 A), with
concentrations as low as 100 pM in the cis solution causing
AB
C
D
FIGURE 2 b1a subunit increases RyR1 channel activity with 10 mM cis
Ca2þ. (A) The b1a subunit (50 nM) was added to the cytoplasmic side of
a single RyR1 channel in a lipid bilayer, recorded at þ40 mV with channel
opening upward from the closed (C) to the maximum open (O) level.
Control activity was recorded before addition of b1a protein. The central
record was obtained ~2 min after addition of the b1a subunit, and the lower
record was acquired several minutes after the cis chamber was perfused to
remove the protein. The left panel shows 3-s records, and the right panel
shows expansions of data underlined by the thick black line in the 3-s
records to illustrate the changes in open duration. (B) Relative PO (log rel
PO) is the average of differences between the log10 of PO in the presence
of the b1a subunit (logPOB) and log10 of the control PO (logPOC) for each
channel, with PO measured over 180 s. (C) The relative mean open time
(log rel TO) is logTOB-logTOC. (D) The relative mean closed time (log rel
TC) is logTCB-logTCC. N ¼ 5–8 experiments for each bin in B–D. Asterisks
indicate significant changes from control induced by the peptide. The
broken lines indicate significant differences between each bin under the
horizontal bracket and data at the far end of the line. In B, log rel PO
with 10–200 nM subunit is significantly greater than PO with buffer; and
log rel PO for 50–200 nM subunit is significantly greater than log rel PO
with 1 nM subunit. In C, log rel TO with 1 nM to 100 nM subunit is signif-
icantly different from log rel TO with buffer.
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FIGURE 3 The 35-residue b1a peptide increases the activity of RyR1
channels with 10 mM cis Ca2þ. (A) Addition of 10 nM of the peptide to
the cytoplasmic side of a single RyR1 channel in a lipid bilayer, recorded
at þ40 mV with channel opening upward from the closed (C) to the
maximum open (O) level. Control data were obtained before addition of
the b1a peptide. The central record was obtained ~3 min after addition of
peptide, and the lower record was acquired several minutes after perfusion
to remove peptide. The left panel shows 3-s records and the right panel
shows expansions of data underlined by the thick black line in the 3-s
records to illustrate the changes in open duration. (B) The relative PO
(log rel PO) is the average of the difference between log10 of PO in the
presence of b1a C-tail peptide (logPOP) and log10 of control PO (logPOC)
for each channel, measured over 180 s. (C) The relative mean open time
(log rel TO) is logTOP-logTOC. (D) The relative mean closed time (log rel
TC) is logTCP-logTcC . N ¼ 5–10 experiments for each bin in B–D. Aster-
isks indicate significant changes from control induced by the peptide. The
broken lines indicate significant differences between each bin under the
horizontal bracket and data at the far end of the line. In B, log rel PO for
10–1000 nM is significantly greater than PO with 0.01–0.1 nM peptide.
In C, log rel TO for 10 and 100 nM is significantly greater than PO with
0.01 nM peptide. In D, log rel TC with 10–1000 nM peptide is significantly
less than log rel TC with 0.1 nM peptide, and log rel TC with 50–1000 nM
peptide is significantly less than log rel TC with 0.01 nM peptide.
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(see, e.g., Fig. 5 A below), although the average increase
in open probability with 100 pM was not significant. Each
channel was exposed to one concentration of b1a peptide
for 15–20 min and then the peptide was removed by perfu-
sion. As with the full-length protein, the effects of the
peptide were not easily reversible, with a clear decrease in
activity seen in only nine of 18 channels after washout of
R10 nM peptide.
The changes in channel activity with the peptide were
again similar at þ40 and 40 mV, with an average 2.7 5
0.6-fold increase in PO (average POP/POC for individual
channels) at 40 mV and a 3.3 5 1.1-fold increase
at þ40 mV with 100 nM peptide. Data obtained at þ40and 40 mV were combined in all averages. The average
increase in open probability with peptide concentrations
R10 nM (Fig. 3 B) could be attributed to a significant
twofold increase in mean open time (Fig. 3 C), and a signif-
icant fourfold decrease in mean closed time (Fig. 3 D).
These changes occurred over the same concentration range
as those induced by the full-length protein and were similar
in magnitude.
The b1a peptide induced a similar increase in RyR1
activity in the presence of 2 mM ATP (and 10 mM Ca2þ)
in the cytoplasmic (cis) solution. The changes in channel
gating and the concentration dependence of the changes
(Fig. 4, A–C) were again very similar to those described
for the full-length b1a subunit. The decrease in the closedBiophysical Journal 100(4) 922–930
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FIGURE 4 Actions of the 35-residue b1a peptide on RyR1 channels in
the presence of 10 mM cis Ca2þ. (A–C) Average values measured over
180 s before and after cytoplasmic addition of the b1a peptide. (A) The rela-
tive PO (log rel PO) is the average of the difference between log10 of PO in
the presence of b1a C-tail peptide (logPOP) and log10 of control PO (logPOC)
for each channel. (B) The relative mean open time (log rel TO) is logTOP-
logTOC. (C) The relative mean closed time (log rel TC) is logTCP-logTcC.
N ¼ 4–6 experiments for each bin in A–C. Asterisks indicate significant
changes from control induced by the peptide. The broken lines indicate
a significant difference between each bin under the horizontal bracket
and data at the far end of the line. In A, log rel PO with 1–500 nM peptide
is significantly different from log rel PO with 0.01 and 0.1 nM peptide. In B,
log rel TO with 0.01 nM peptide is significantly greater than log rel TO with
1, 50, and 100 nM peptide. In C, log rel TC with 1–500 nM peptide is signif-
icantly less than log rel TC with 0.1 nM peptide, and 10–100 nM is signif-
icantly less than 0.01 nM peptide. (D and E) Least-squares fit of a standard
Hill equation to the average PO expressed as average POB/POC (open circles
for b1a subunit) or POP/POC (solid circles for b1a peptide), calculated for
individual channels in the absence (D) and presence (E) of ATP. The fit
parameters are given in the text.
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FIGURE 5 (A) Stability and specificity of the effects of the b1a peptide on
RyR1 activity in the presence of ATP. Open probability (PO) is plotted
against time for the entire experiment. Peptide concentrations (from the
top down): 100 pM, 10 nM, 100 nM, and 500 nM. (B) The bscrambled peptide
does not alter RyR1 channel activity. Channel opening upward at þ40 mV
from the closed (C) to the maximum open level (O) before (control) and
after addition of 100 nM bscrambled peptide. (C) Average relative PO (POP/
POC) after exposure to 10 and 100 nM bscrambled peptide (N ¼ 7 experi-
ments).
926 Rebbeck et al.durations was greater than the increase in open times, again
indicating an additional effect on the dwell time in the
closed state. This resulted in an increase in the frequency
of openings 3.8 5 0.2-fold with 10 nM peptide and
increases of ~2.5–3.0-fold with other concentrations up to
500 nM.
The open probabilities of channels exposed to the
full-length b1a subunit and the b1a peptide are plotted
as the average POB/POC (for b1a subunit) or POP/POC
(b1a peptide) in Fig. 4, D and E, respectively. The data
were fitted with a standard Hill equation (see Materials
and Methods). The best least-squares fit to the data was ob-
tained with AC50¼ 450 pM and Ha¼ 1.5, in the presence orBiophysical Journal 100(4) 922–930absence of ATP. The Hill coefficient of 1.5 indicates that
binding to two subunits of the RyR tetramer may be suffi-
cient to increase RyR1 channel activity. It is possible that
a binding pocket is formed at the interface between two
subunits.
The stability of the b1a peptide effect on channel activity
is illustrated in Fig. 5 A. The open probability was measured
continuously during 20-min exposures to the b1a peptide
with 1 mM cis ATP. Activity increased within 2–3 min of
peptide addition and remained constant until the channel
was blocked by ruthenium red (confirming that the channel
was RyR1). Similar stability was observed with the full b1a
subunit and peptide in the absence of ATP.
The specificity for the native sequence of the b1a
C-terminal tail in increasing RyR1 activity was assessed
by addition of 10 or 100 nM of the bscrambled peptide to
the cis side of RyR1 channels. The bscrambled peptide had
no effect on the channels (Fig. 5, B and C), indicating that
an increase in activity required the specific native amino
acid sequence in the C-terminal 35 residues of the b1a
subunit.
b1a Subunit of the Skeletal DHPR and RyR1 927The b1a C-tail peptide causes a Ca
2D-dependent
increase in [3H]ryanodine binding
[3H]Ryanodine binding was measured as an independent
indicator of channel activity. A significant increase in [3H]
ryanodine binding was observed when 50 nM and 1 mM
of b1a peptide was added to SR vesicles in the presence of
10 mM Ca2þ (Fig. 6 A). This is indicative of an increase
in RyR1 channel activity, since ryanodine binding increases
as RyR1 activity increases (14). The binding with 1 mM
peptide was significantly less than that achieved withA
B
C
FIGURE 6 b1a peptide increases [
3H]ryanodine binding in a Ca2þ-
dependent manner. (A) Average [3H]ryanodine binding with 50 or 1000
nM b1a peptide (solid bins) or bscrambled peptide (hatched bins) relative to
binding with no peptide. (B) Average relative [3H]ryanodine binding as
a function of b1a peptide concentration. Binding with 1, 10, and 50 nM
peptide was significantly greater than with 1, 10, and 100 pM peptide,
whereas binding with 500 pM was significantly greater than with 1 pM
and significantly less than with 50 nM peptide. The line through the data
is the best least-squares fit of a standard Hill equation with parameters given
in the text. (C) Average [3H]ryanodine bound (pmol) per milligram of SR
without (control), and with 50 nM b1a peptide at the indicated [Ca
2þ]. In
A–C, asterisks indicate a significant increase in [3H]ryanodine binding
with peptide compared with 3H]ryanodine binding in the absence of peptide
(N ¼ 6–18 for each bin).50 nM peptide, possibly due to a nonspecific effect of the
high concentration of peptide. This was not explored further.
The bscrambled peptide had no effect on [
3H]ryanodine
binding at either 50 nM or 1 mM (Fig. 6 A). The dependence
of [3H]ryanodine binding on b1a peptide concentration is
shown in Fig. 6 B. The curve through the data is the best
least-squares fit of a Hill equation with AC50 ¼ 600 pM
and Ha ¼ 1.1. These parameters are remarkably close to
those obtained for the increase in open probability in
single-channel experiments (above).
The effect of the b1a peptide on [
3H]ryanodine binding
was dependent on [Ca2þ] (Fig. 6 C). The usual increase in
[3H]ryanodine binding, reflecting high-affinity Ca2þ-activa-
tion of RyR1, was seen as [Ca2þ] increased from 100 nM to
100 mM. A further increase in [Ca2þ] to 1 mM was accom-
panied by a decline in ryanodine binding, reflecting lower-
affinity Ca2þ inhibition (15,16). A significant increase in
[3H]ryanodine binding with 50 nM b1a peptide was seen
only with 1 and 10 mM Ca2þ. There was no effect of
the peptide with subactivating 100 nM Ca2þ, maximally
activating 100 mM Ca2þ, or inhibiting 1 mM Ca2þ. The
lack of an effect with 100 mM Ca2þ cannot be attributed
to saturation of channel opening, since PO in the maximally
Ca2þ-activated channel is well below 1.00, and significantly
greater binding can be seen when additional activators are
added (14). Ryanodine binding is clearly not saturated
with 100 nM or 1 mM Ca2þ.
The apparent Ca2þ dependence of b1a effects was further
explored in single-channel experiments in which the peptide
was added to a cytoplasmic solution containing 100 nM
Ca2þ. There was no change in activity during exposure to
10 nM b1a peptide or within 10 min after b1a peptide was
increased to 100 nM (Fig. 7 A). There was no increase in
average PO measured from 180 s of channel activity under
either condition (Fig. 7 B). However in two of the five exper-
iments, occasional longer channel openings could be seen
(arrows in Fig. 7 A), perhaps reflecting a weak effect of
the b1a peptide.
Under physiological conditions, low resting RyR1
activity is maintained by 1–4 mM [Mg2þ] binding to the
low-affinity inhibitory site, which has a similar sensitivity
to Ca2þ and Mg2þ (16). Mg2þ inhibition is relieved by
a signal from the DHPR during EC coupling (17,18). We
examined the ability of the b1a peptide to activate RyR1
channels in the presence of 4 mM Mg2þ and 1 mM ATP.
Addition of Mg2þ reduced channel activity to very low
levels and there was no increase after 5–10 min incubation
with 50 nM and then 400 nM b1a peptide (Fig. 7 C). Subse-
quent addition of 10 mM caffeine produced a significant
increase in activity. In contrast to the lack of activation
Mg2þ-inhibited channels, the b1a peptide induced signifi-
cant activation of channels with 100 nM cis Ca2þ when
channel activity was enhanced by 1 mM cis ATP (but no
Mg2þ; Fig. 7 D). Consistent with the channel data, the b1a
peptide was unable to increase Ca2þ release from SRBiophysical Journal 100(4) 922–930
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FIGURE 7 b1a peptide does not increase the activity of RyR1 channels
that are inactive with 100 nM cytoplasmic (cis) Ca2þ or inhibited by
Mg2þ. (A) Three 30-s (90 s total) records from one channel at þ40 mV:
before (i) and 6–8 min after addition of 10 nM b1a peptide (ii) and
90 nM b1a peptide (iii). The arrows indicate occasional bursts of activity
with peptide that did not significantly alter PO over the 90-s period. (B)
Average relative PO (as defined for Figs. 2–4, for 10 and 100 nM b1a peptide
added to a 100 nM Ca2þ cis solution. (C) Average relative PO with 10 mM
cis Ca2þ (control), and after sequential additions of 1 mM ATP, 4 mM
Mg2þ, 50 nM b1a peptide, 350 nM b1a peptide, and 10 mM caffeine
(N ¼ 7 experiments). (D) Average relative PO with 100 nM cis Ca2þ
(control) and after addition of 1 mM ATP and then 10 nM and 90 nM b1a
peptide. Asterisks indicate significant differences between control values
and values with peptide (N ¼ 4 observations from two experiments). The
broken lines (C and D) indicate significant differences between average
data under the horizontal bracket and data at the far end of the line. In C,
log rel PO with 4mM Mg
2þ, 50 nM, and 400 nM peptide is significantly
different from log rel PO with 1 mM ATP alone or with 10 mM caffeine.
In D, log rel PO with 10 and 100 nM peptide is significantly different
from log rel PO with ATP alone.
928 Rebbeck et al.vesicles (bathed in 1 mM ATP and 4 mM Mg2þ to load of
Ca2þ (19); N ¼ 30). Ca2þ release in these experiments
was evoked by 1–10 mM caffeine. Together, these data indi-
cate that RyR1 activity had a specific effect on the ability of
the b1a peptide to activate the channel.DISCUSSION
The results presented here reveal for the first time, to our
knowledge, a functional interaction between the b1a subunit
of the skeletal DHPR and the skeletal RyR1 channel. The
full-length b1a subunit was previously shown to bind to
RyR1 fragments (7), and the 35-residue C-tail of b1a was
shown to support EC coupling (6). Here, we show that the
35 C-terminal tail residues of b1a bind to the full-lengthBiophysical Journal 100(4) 922–930RyR1. This result supports the possibility of a direct phys-
ical interaction between the C-terminal tail of the b1a
subunit and RyR1 in vivo. In addition, we show for the first
time, to our knowledge, that the full-length b1a subunit
induces an increase in the activity of RyR1 when added to
the cytoplasmic side of the channel, and that the C-terminal
35 residues are sufficient to support this increase in RyR1
channel activity. The functional interaction with the RyR1
channel was significant with only 500 pM to 1 nM of either
b1a subunit or its C-terminal tail, and increases in individual
RyR1 channel openings were seen with only 100 pM
peptide. The binding and functional interaction between
the b1a peptide and RyR1 was specific for the native
sequence of the C-terminal 35 residues in the b1a subunit,
as no binding or change in activity was seen with a peptide
having a scrambled sequence of the same residues. Thus,
there is a specific physical and very-high-affinity functional
interaction between the C-terminal tail of the b1a subunit
and the RyR1 channel.
As noted in the Introduction, previous experiments in b1a-
null mouse mytotubes transfected with various constructs of
the C-terminal tail of the b1a subunit suggested that b1a may
contribute directly to physical EC coupling in skeletal
muscle (6,7). Experiments with the b1a-null zebrafish could
also be interpreted in terms of a direct participation of the
b1a subunit in the physical EC coupling process, although
other interpretations were favored by the authors (8). The
fact that the b1a subunit can bind to RyR1 fragments in
affinity chromatography indicates that the effect of b1a on
voltage-dependent Ca2þ release may be mediated by its
binding to RyR1 (7). The impact of the C-terminal tail of
b1a on EC coupling (6) further suggests that the C-terminal
tail may be involved in b1a binding to RyR1. Our results
provide the first direct evidence (to our knowledge) that
the b1a C-terminal tail binds to the full-length RyR1, and
that this results in a high-affinity (picomolar) functional
interaction between the b1a subunit and the RyR1 proteins
that may contribute to Ca2þ release during in vivo
contraction.
However, the notion that the b1a subunit contributes
directly to in vivo Ca2þ release is controversial (2). As
mentioned above, Schredelseker et al. (8) questioned this
view and argued that apparent effects on Ca2þ release could
be due to a specific effect of the b1a on microtargeting of the
DHPR to RyR1. In a study by Sheridan et al. (20), alanine
substitution of specific residues in a hydrophobic heptad
repeat (i.e., three hydrophobic residues each separated by
seven residues) in the C-terminal 47 residues (b1a 478–
524) of the b1a subunit reduced EC coupling. Curiously,
however, alanine substitution of the hydrophobic residues
that abolished voltage-dependent Ca2þ release in a mouse
model did not alter Ca2þ release in a zebrafish model
(21). It is worth noting that two of these three hydrophobic
residues in the heptad repeat are outside the extreme 35-
residue C-tail (residues 490–524) that was previously shown
b1a Subunit of the Skeletal DHPR and RyR1 929to influence EC coupling (6) and was shown here to be suffi-
cient to reproduce the effects of the full-length b1a. The role
of the heptad repeat remains to be resolved. It may be more
important for the interaction between the b1a C-terminal tail
and RyR1 in the mouse myotube than in the zebrafish
because of small differences between the two tissues in
either the structure of the T-tubule/SR junction or the
RyR1 sequence. On the other hand, our preliminary data
suggest that hydrophobic residues 409, 500, and 504 (in
positions 7, 11, and 14 at the N-terminus of the 35-residue
C-tail peptide) are required for the functional interaction
between the peptide and RyR1. Of note, residues 11 and
14 are not part of the heptad repeat.
The action of the b1a C-terminal tail peptide on RyR1
channels was dependent on cytoplasmic Ca2þ, ATP, and
Mg2þ concentrations, such that the peptide was active
when channel activity was high (in the presence of 10 mM
cytoplasmic Ca2þ and/or 1 mM ATP) and was inactive
when channel activity was low (inhibited by Mg2þ). Thus,
the peptide was most active under conditions achieved
during voltage-activated Ca2þ release, i.e., 1 and 10 mM
cytoplasmic Ca2þ and release of Mg2þ inhibition (17,18).
It is not clear from our experiments whether the response
to the b1a peptide is set by the level of channel activity or
the actual concentrations Ca2þ and Mg2þ. The data suggest
that the level of activity may be the principal factor, because
the peptide was inactive with 100 nM Ca2þ alone but active
when ATP was added. Regardless of the mechanism, this
result indicates that the functional interaction between b1a
and RyR1 may become significant only after voltage-acti-
vated Ca2þ release has been initiated and Mg2þ inhibition
has been relieved. In this case, the b1a / RyR1 pathway
could act as a booster system in the Ca2þ release process.
The role of the C-tail of the b1a subunit in EC coupling
and binding to RyR1 is also brought into question by the
results of FRET experiments using a CFP-YFP tandem
construct fused to b1a (22). First, b1a expressed without
a1s was not colocalized with RyRs, suggesting that b1a
cannot bind to RyR1 in the absence of a1S. However, this
result could also be explained by other factors, including
the geometry of the junction, which may be altered in the
absence of a1s so that access to b1a is restricted. Second,
the FRETefficiency of the CFP-YFP tandem construct fused
to the b1a C-tail was similar when the construct was ex-
pressed in a1S-null or RyR1-null myotubes, indicating that
the C-terminal tail does not bind to RyR1. Again, this could
be explained by other factors, including the possibility that
the binding site involves hydrophobic residues remote from
the extreme C-terminus (as discussed above). Finally, fusion
to the CFP-YFP tandem construct to the b1a C-terminus did
not alter the percentage of myotubes that contracted in
response to electrical stimulation, which could indicate
that the C-tail is not essential for EC coupling. This may
also be explained by the fact that the extremity of the
C-tail is removed from the critical hydrophobic site forbinding to RyR1. Additional questions arise because it has
been shown that a biotin acceptor domain tag fused to the
C-terminus of b1a is accessible to a 60-kD streptavidin
probe, and EC coupling persists after streptavidin binds
to the biotin acceptor (23). This suggests that the b1a
C-terminus does not interact directly with RyR1 in the
resting state (2). As with the other observations, this result
could be explained by other factors. For example, because
binding to RyR1 occurs at a site removed from the extreme
b1a C-terminus, the conformation of the site is not influ-
enced by streptavidin that is bound to an acceptor attached
to the extreme C-terminus.
It remains curious that the b1a subunit does not copurify
with RyR1 even though we see a high-affinity interaction
between the proteins in vitro. This may be due in part to
the similarly high-affinity binding of the b1a subunit to
a1S I-II loop. It is possible that 1), b1a binding to RyR1 is
destabilized by the detergents used for purification (since
hydrophobic residues appear to be involved in the binding;
see Discussion above); or 2), the effective b1a binding
to RyR1 is only permitted with conformational changes
that may occur within the a1S/b1a complex during EC
coupling.CONCLUSIONS
Our results show that there is a specific high-affinity acti-
vating interaction between the b1a subunit of the DHPR
and RyR1. This effect of the full-length b1a subunit can be
reproduced by a peptide corresponding to the 35-residue
C-terminal tail of the b1a subunit, indicating that the action
of the subunit is mediated by its C-terminal residues.
We conclude that the high-affinity interaction between the
C-terminal tail of b1a and RyR1 may contribute to an EC
coupling signaling pathway. This conclusion is supported
by previous results from mouse myotube experiments indi-
cating that both the C-terminal tail of b1a and binding of the
b1a subunit to RyR1 are required for proper skeletal-type EC
coupling.
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